Search Results - "VEGRAN, Frédérique"
-
1
Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors
Published in Cancer research (Chicago, Ill.) (15-02-2012)“…The monocarboxylate transporter (MCT) family member MCT1 can transport lactate into and out of tumor cells. Whereas most oxidative cancer cells import lactate…”
Get full text
Journal Article -
2
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Published in Cancer research (Chicago, Ill.) (15-09-2016)“…Host immunity controls the development of colorectal cancer, and chemotherapy used to treat colorectal cancer is likely to recruit the host immune system at…”
Get full text
Journal Article -
3
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
Published in Cancers (16-05-2022)“…During carcinogenesis, tumors set various mechanisms to help support their development. Angiogenesis is a crucial process for cancer development as it drives…”
Get full text
Journal Article -
4
Canonical and non-canonical functions of NLRP3
Published in Journal of advanced research (01-11-2023)“…[Display omitted] •Presents an overview on the knowledge acquired on the role NLRP3 in its canonical function.•Gives an insight on NLRP3 newly discovered…”
Get full text
Journal Article -
5
SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer Growth
Published in Cancer research (Chicago, Ill.) (15-06-2013)“…Activation of the transcription factor PPARγ by the n-3 fatty acid docosahexaenoic acid (DHA) is implicated in controlling proinflammatory cytokine secretion,…”
Get full text
Journal Article -
6
Survivin-3B Potentiates Immune Escape in Cancer but Also Inhibits the Toxicity of Cancer Chemotherapy
Published in Cancer research (Chicago, Ill.) (01-09-2013)“…Dysregulation in patterns of alternative RNA splicing in cancer cells is emerging as a significant factor in cancer pathophysiology. In this study, we…”
Get full text
Journal Article -
7
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Published in Oncotarget (10-01-2017)“…Until recently, the molecular diagnosis of hereditary breast and ovarian cancer (HBOC) was mostly based on BRCA1/2 testing. Next generation sequencing and the…”
Get full text
Journal Article -
8
Overexpression of Caspase-3s Splice Variant in Locally Advanced Breast Carcinoma Is Associated with Poor Response to Neoadjuvant Chemotherapy
Published in Clinical cancer research (01-10-2006)“…Purpose: CASP-3 gene gives rise, by alternative splicing to a caspase-3s variant, to the antagonist apoptotic property of caspase-3. Deregulation of splicing…”
Get full text
Journal Article -
9
Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis
Published in Cancer research (Chicago, Ill.) (01-04-2011)“…Lactate generated from pyruvate fuels production of intracellular NAD(+) as an end result of the glycolytic process in tumors. Elevated lactate concentration…”
Get full text
Journal Article -
10
Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy
Published in International journal of molecular medicine (01-02-2009)“…Survivin, a member of the apoptosis inhibitor protein family, is expressed in numerous human tumours, and its expression is described as a negative prognostic…”
Get full text
Journal Article -
11
The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas
Published in Genes chromosomes & cancer (01-04-2008)“…Expression of BIRC5 (survivin), a member of the inhibitor of apoptosis protein (IAP) family, is elevated in fetal tissues and in various human cancers…”
Get full text
Journal Article -
12
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
Published in Oncoimmunology (03-06-2018)“…Background: Chemotherapy is currently evaluated in order to enhance the efficacy of immune checkpoint blockade (ICB) therapy in colorectal cancer. However, the…”
Get full text
Journal Article -
13
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
Published in Nature immunology (01-02-2022)“…Tumors poorly infiltrated by T cells are more resistant to immunogenic chemotherapies and checkpoint inhibition than highly infiltrated tumors. Using murine…”
Get full text
Journal Article -
14
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Published in Nature Medicine (01-01-2013)“…Gemcitabine and 5-fluorouracil are two commonly used chemotherapeutic agents for the treatment of cancer. François Ghiringhelli and colleagues now report that…”
Get full text
Journal Article Magazine Article -
15
Alternative Splicing in Cancer and Immune Cells
Published in Cancers (28-03-2022)“…Splicing is a phenomenon enabling the excision of introns from pre-mRNA to give rise to mature mRNA. All the 20,000 genes of the human genome are concerned by…”
Get full text
Journal Article -
16
Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis
Published in PloS one (13-03-2012)“…Switching to a glycolytic metabolism is a rapid adaptation of tumor cells to hypoxia. Although this metabolic conversion may primarily represent a rescue…”
Get full text
Journal Article -
17
Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
Published in Frontiers in immunology (08-03-2023)Get full text
Journal Article -
18
Impact of Lipid Metabolism on Antitumor Immune Response
Published in Cancers (06-04-2022)“…Over the past decade, metabolic reprogramming has been defined as a hallmark of cancer. More recently, a large number of studies have demonstrated that…”
Get full text
Journal Article -
19
Th9 cells: a novel CD4 T-cell subset in the immune war against cancer
Published in Cancer research (Chicago, Ill.) (01-02-2015)“…CD4 T cells are key components of the immune system that shape the anticancer immune response in animal models and in humans. The biology of CD4 T cells is…”
Get full text
Journal Article -
20
Transcriptional regulation of the survivin gene
Published in Molecular biology reports (01-01-2014)“…Survivin, a small member of the inhibitors of the apoptosis protein family, is highly deregulated in cancer. It is weakly expressed in normal tissues but very…”
Get full text
Journal Article